AC8 — Auscann group Income Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedMicro Cap
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.862 | 0.389 | 1.82 | 1.64 | 1.87 |
Cost of Revenue | |||||
Gross Profit | — | 0.386 | 1.75 | 1.6 | 1.87 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.84 | 7.46 | 12.4 | 26.6 | 12.6 |
Operating Profit | -6.98 | -7.08 | -10.6 | -24.9 | -10.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.65 | -7.08 | -10.6 | -24.9 | -10.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.65 | -7.08 | -10.6 | -24.9 | -10.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -7.65 | -7.08 | -8.64 | -26.4 | -10.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.65 | -7.08 | -8.64 | -26.4 | -10.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.02 | -0.02 | -0.019 | -0.011 | -0.024 |